erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
i just called to see how you guys are doing. give us a call � i hope you're having a good time, wherever you are.
.
. check out original content and videos published every day to help you learn about the issues that mean the most to you.
.
advertisement
.
the study used data of 1,082 ct scans of stroke patients across 70 hospitals in britain.
.